Ziad Bakri, CFA, MD, Portfolio Manager
- M.D., University of Nottingham
Ziad Bakri is a portfolio manager in the U.S. Equity Division of T. Rowe Price. He is president of the Investment Advisory Committee of the Health Sciences Strategy. In addition, he is a vice president and an Investment Advisory Committee member of the Blue Chip Growth, New America Growth, New Horizons, Mid-Cap Growth, and Tax-Efficient Equity Strategies. Mr. Bakri is also an Investment Advisory Committee member of the Global Growth Stock Strategy and a vice president of the Emerging Europe Strategy. Previously, he was an investment analyst in the U.S. Equity Division, covering biotechnology in the health care sector. Mr. Bakri is a vice president of T. Rowe Price Group, Inc.
Mr. Bakri has 14 years of investment experience, eight of which have been with T. Rowe Price. Prior to joining the firm in 2011, he was a vice president in equity research at Cowen and Company, where he also covered biotechnology companies. Prior to this, Mr. Bakri was a health care investment banking analyst with Merrill Lynch in London.
Mr. Bakri is a medical doctor and was an emergency medicine resident at the Royal London Hospital in the UK. He earned a bachelor of medical science degree, with first-class honors, from the University of Nottingham and bachelor of medicine, bachelor of surgery, degree from the University of Nottingham, Medical School. Mr. Bakri also has earned the Chartered Financial Analyst designation.
- Years at T. Rowe Price10
- Years investment experience16